124 related articles for article (PubMed ID: 8036683)
1. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London.
Bryceson AD; Murphy A; Moody AH
Trans R Soc Trop Med Hyg; 1994; 88(2):226-8. PubMed ID: 8036683
[TBL] [Abstract][Full Text] [Related]
2. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
Neal RA; Murphy AG; Olliaro P; Croft SL
Trans R Soc Trop Med Hyg; 1994; 88(2):223-5. PubMed ID: 8036682
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F
Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
[TBL] [Abstract][Full Text] [Related]
5. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
6. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
Hepburn NC; Tidman MJ; Hunter JA
Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
[TBL] [Abstract][Full Text] [Related]
8. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis.
Soto J; Grogl M; Berman J; Olliaro P
Trans R Soc Trop Med Hyg; 1994; 88(6):695-8. PubMed ID: 7886777
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
Sahibzada NJ; Tareen AK; Khursheed T; Darr N
J Pak Med Assoc; 1996 Mar; 46(3):53-5. PubMed ID: 8991348
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
el-On J; Halevy S; Grunwald MH; Weinrauch L
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
Iraji F; Sadeghinia A
Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
Ben Salah A; Zakraoui H; Zaatour A; Ftaiti A; Zaafouri B; Garraoui A; Olliaro PL; Dellagi K; Ben Ismail R
Am J Trop Med Hyg; 1995 Aug; 53(2):162-6. PubMed ID: 7677218
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cutaneous leishmaniasis by photodynamic therapy.
Gardlo K; Horska Z; Enk CD; Rauch L; Megahed M; Ruzicka T; Fritsch C
J Am Acad Dermatol; 2003 Jun; 48(6):893-6. PubMed ID: 12789181
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Leishmaniasis in an American Adolescent Returning From Israel.
Ganjaei KG; Lawton K; Gaur S
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e178-e181. PubMed ID: 29878238
[TBL] [Abstract][Full Text] [Related]
16. Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica.
Teklemariam S; Hiwot AG; Frommel D; Miko TL; Ganlov G; Bryceson A
Trans R Soc Trop Med Hyg; 1994; 88(3):334-9. PubMed ID: 7974682
[TBL] [Abstract][Full Text] [Related]
17. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
el-On J; Sulitzeanu A; Schnur LF
Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981
[TBL] [Abstract][Full Text] [Related]
18. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom.
Scott JA; Davidson RN; Moody AH; Grant HR; Felmingham D; Scott GM; Olliaro P; Bryceson AD
Trans R Soc Trop Med Hyg; 1992; 86(6):617-9. PubMed ID: 1287915
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
Ozgoztasi O; Baydar I
Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
[TBL] [Abstract][Full Text] [Related]
20. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
El-On J; Bazarsky E; Sneir R
Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
